Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (3) Beule, Dieter Dr. (2) Birchmeier-Kohler, Carmen Prof. Dr. (2) Bunse, Mario Dr. (1) Cakmak-Görür, Nese Dr. (1) Chekulaeva, Marina Dr. (1) Chen, Wei Prof. Dr. (1) Clauß, Julian (1) Costanza, Mariantonia Dr. (1) Daumke, Oliver Prof. Dr. (1) Dhamodaran, Arunraj (1) Diecke, Sebastian Dr. (1) Franke, Vedran Dr. (2) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Janz, Martin Dr. (5) Kammertöns, Thomas Dr. (2) Kastelic, Nicolai (1) Kempa, Stefan Dr. (1) Kieback, Elisa Dr. (1) Kirchner, Marieluise Dr. (2) Kolesnichenko, Marina Dr. (1) Kühn, Ralf Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lewin, Gary Prof. Dr. (1) Lorenz, Felix Dr. (1) Lusatis, Simone (1) Marko, Lajos Dr. (1) Mathas, Stephan Dr. (7) Meyer, Irmtraud Margret Prof. Dr. (1) Na, Il-Kang Dr. (1) Ohler, Uwe Prof. Dr. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Poncette, Lucia (1) Rajewsky, Nikolaus Prof. Dr. (1) Rehm, Armin Dr. (1) Rhein, Simone Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (2) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (13) Sommer, Christian (1) Uckert, Wolfgang Prof. Dr. (3) Uyar, Bora Dr. (1) Walther, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (5) Willnow, Thomas Prof. Dr. (1) Woehler, Andrew Dr. (1) Zauber, Henrik Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (30) (-) Daniel, Peter Prof. Dr. (1) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (3) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immundysregulationen in der Onkologie (1) Immunregulation und Krebs (1) (-) Molekulare Immunologie und Gentherapie (30) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (2) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) (-) 1994 (5) (-) 1995 (8) (-) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (4) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (4) 2015 (5) 2016 (4) 2017 (6) (-) 2018 (4) (-) 2019 (6) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 33 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 199419951996200620182019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Januar 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin 01. Januar 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier 30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky 01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel 01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein 27. November 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Seite 4 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Januar 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin
01. Januar 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier
30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky
01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein
27. November 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule